Prognostic role of circulating tumor cells in patients with pancreatic cancer: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 15, 2014, Pages 6015-6020

  Ma, Xue Lei ^a   Li, Yan Yan ^a   Zhang, Jing ^a   Huang, Jing Wen ^a   Jia, Hong Yuan ^a   Liu, Lei ^a   Li, Ping ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

CTCs; Meta analysis; Pancreatic; Prognosis

Indexed keywords

TUMOR MARKER;

CASE CONTROL STUDY; HUMAN; META ANALYSIS; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; TUMOR EMBOLISM;

BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; HUMANS; NEOPLASTIC CELLS, CIRCULATING; PANCREATIC NEOPLASMS; PROGNOSIS;

EID: 84906274430     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.15.6015     Document Type: Article

References (32)

1. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
2. Bidard FC, Huguet F, Louvet C, et al (2013). Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. Ann Oncol, 24, 2057-61.
3. Cen P, Ni X, Yang J, et al (2012). Circulating tumor cells in the diagnosis and management of pancreatic cancer. Biochim Biophys Acta, 1826, 350-6.
4. Cohen SJ, Punt CJ, Iannotti N, et al (2008). Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol, 26, 3213-21.
5. Cristofanilli M, Budd GT, Ellis MJ, et al (2004). Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med, 351, 781-91.
6. de Albuquerque A, Kubisch I, Breier G, et al (2012). Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study, Oncology, 82, 3-10.
7. Dong X, Alpaugh KR, Cristofanilli M (2012). Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis. Chin J Cancer Res, 24, 388-98.
8. Ghaneh P, Costello E, Neoptolemos JP (2008). Biology and management of pancreatic cancer. Postgrad Med J, 84, 478-97.
9. Goodman OB, Jr Symanowski JT, Loudyi A, et al (2011). Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer. Clin Genitourin Cancer, 9, 31-8.
10. Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
11. Hiltermann TJ, Pore MM, van den Berg, et al (2012). Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. Ann Oncol, 23, 2937-42.
12. Hofman V, Ilie MI, Long E, et al (2011). Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay and the isolation by size of epithelial tumor cell method. Int J Cancer, 129, 1651-60.
13. Khoja L, Backen A, Sloane R, et al (2012). A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer, 106, 508-16.
14. Kokhanenko, NIu, Ignashov AM, et al (2001). Role of the tumor markers CA 19-9 and carcinoembryonic antigen (CEA) in diagnosis, treatment and prognosis of pancreatic cancer. Vopr Onkol, 47, 294-7.
15. Kowalewska M, Chechlinska M, Markowicz S, et al (2006). The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytes. Eur J Cancer, 42, 2671-4.
16. Kurihara T, Itoi T, Sofuni A, et al (2008). Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result. J Hepatobiliary Pancreat Surg, 15, 189-95.
17. Ma XL, Xiao ZL, Liu L, et al (2012). Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer. Asian Pac J Cancer Prev, 13, 1137-44.
18. Mataki Y, Takao S, Maemura K, et al (2004). Carcinoembryonic antigen messenger RNA expression using nested reverse transcription-PCR in the peripheral blood during followup period of patients who underwent curative surgery for biliary-pancreatic cancer: longitudinal analyses. Clin Cancer Res, 10, 3807-14.
19. Muller P, Schlimok G (2000). Bone marrow "micrometastases" of epithelial tumors: detection and clinical relevance. J Cancer Res Clin Oncol, 126, 607-18.
20. Parmar MK, Torri V, Stewart L (1998). Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med, 17, 2815-34.
21. Sergeant G, Roskams T, van Pelt J, et al (2011). Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma. BMC Cancer, 11, 47.
22. Sergeant G, van Eijsden R, Roskams T, et al (2012). Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery. BMC Cancer, 12, 527.
23. Soeth E, Grigoleit U, Moellmann B, et al (2005). Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival. J Cancer Res Clin Oncol, 131, 669-76.
24. Tarhan MO, Gonel A, Kucukzeybek Y, et al (2013). Prognostic significance of circulating tumor cells and serum CA15-3 levels in metastatic breast cancer, single center experience, preliminary results. Asian Pac J Cancer Prev, 14, 1725-9.
25. Tierney JF, Stewart LA, Ghersi D, et al (2007). Practical methods for incorporating summary time-to-event data into metaanalysis. Trials, 8, 16.
26. Tjensvoll K, Nordgard O, Smaaland R (2013). Circulating tumor cells in pancreatic cancer patients: Methods of detection and clinical implications, Int J Cancer, 8, 16.
27. Uchikura K, Takao S, Nakajo A, et al (2002). Intraoperative molecular detection of circulating tumor cells by reverse transcription-polymerase chain reaction in patients with biliary-pancreatic cancer is associated with hematogenous metastasis. Ann Surg Oncol, 9, 364-70.
28. Uen YH, Lu CY, Tsai HL, et al (2008). Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection. Ann Surg Oncol, 15, 2120-8.
29. Wang FB, Yang XQ, Yang S, et al (2011). A higher number of circulating tumor cells (CTC) in peripheral blood indicates poor prognosis in prostate cancer patients-a meta-analysis. Asian Pac J Cancer Prev, 12, 2629-35.
30. Williamson PR, Smith CT, Hutton JL, et al (2002). Aggregate data meta-analysis with time-to-event outcomes, Stat Med, 21, 3337-51.
31. Zhou J, Hu L, Yu Z, et al (2011). Marker expression in circulating cancer cells of pancreatic cancer patients. J Surg Res, 171, 631-6.
32. Zippelius A, Pantel K (2000). RT-PCR-based detection of occult disseminated tumor cells in peripheral blood and bone marrow of patients with solid tumors. An overview. Ann N Y Acad Sci, 906, 110-23.